Velmanase alfa-tycv: first FDA approval for non-CNS indications of alpha-mannosidosis

Published Date: 18 Feb 2023

Velmanase alfa-tycv: first FDA approval for non-CNS indications of alpha-mannosidosis

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Males with early-onset colorectal cancer are at risk, according to a study.

2.

For elderly, unfit patients, the all-oral AML regimen shows promise.

3.

Targeted First-Line Combo Approved for EGFR-Mutated Lung Cancer

4.

Detecting invasive nodules could be key to preventing unnecessary pancreatic cancer surgery

5.

Neural networks and label-free microscopy enable accurate detection of pancreatic tumors


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot